Literature DB >> 15004239

Tyrosine phosphorylation of Sprouty proteins regulates their ability to inhibit growth factor signaling: a dual feedback loop.

Jacqueline M Mason1, Debra J Morrison, Bhramdeo Bassit, Manjari Dimri, Hamid Band, Jonathan D Licht, Isabelle Gross.   

Abstract

Sprouty proteins are recently identified receptor tyrosine kinase (RTK) inhibitors potentially involved in many developmental processes. Here, we report that Sprouty proteins become tyrosine phosphorylated after growth factor treatment. We identified Tyr55 as a key residue for Sprouty2 phosphorylation and showed that phosphorylation was required for Sprouty2 to inhibit RTK signaling, because a mutant Sprouty2 lacking Tyr55 augmented signaling. We found that tyrosine phosphorylation of Sprouty2 affected neither its subcellular localization nor its interaction with Grb2, FRS2/SNT, or other Sprouty proteins. In contrast, Sprouty2 tyrosine phosphorylation was necessary for its binding to the Src homology 2-like domain of c-Cbl after fibroblast growth factor (FGF) stimulation. To determine whether c-Cbl was required for Sprouty2-dependent cellular events, Sprouty2 was introduced into c-Cbl-wild-type and -null fibroblasts. Sprouty2 efficiently inhibited FGF-induced phosphorylation of extracellular signal-regulated kinase 1/2 in c-Cbl-null fibroblasts, thus indicating that the FGF-dependent binding of c-Cbl to Sprouty2 was dispensable for its inhibitory activity. However, c-Cbl mediates polyubiquitylation/proteasomal degradation of Sprouty2 in response to FGF. Last, using Src-family pharmacological inhibitors and dominant-negative Src, we showed that a Src-like kinase was required for tyrosine phosphorylation of Sprouty2 by growth factors. Thus, these data highlight a novel negative and positive regulatory loop that allows for the controlled, homeostatic inhibition of RTK signaling.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15004239      PMCID: PMC404014          DOI: 10.1091/mbc.e03-07-0503

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  46 in total

1.  The receptor tyrosine kinase regulator Sprouty1 is a target of the tumor suppressor WT1 and important for kidney development.

Authors:  Isabelle Gross; Debra J Morrison; Deborah P Hyink; Kylie Georgas; Milton A English; Mathias Mericskay; Seiyu Hosono; David Sassoon; Patricia D Wilson; Melissa Little; Jonathan D Licht
Journal:  J Biol Chem       Date:  2003-07-25       Impact factor: 5.157

2.  The Src family tyrosine kinases are required for platelet-derived growth factor-mediated signal transduction in NIH 3T3 cells.

Authors:  G M Twamley-Stein; R Pepperkok; W Ansorge; S A Courtneidge
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-15       Impact factor: 11.205

3.  Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain.

Authors:  M Treier; L M Staszewski; D Bohmann
Journal:  Cell       Date:  1994-09-09       Impact factor: 41.582

4.  Mammalian Sprouty4 suppresses Ras-independent ERK activation by binding to Raf1.

Authors:  Atsuo Sasaki; Takaharu Taketomi; Reiko Kato; Kazuko Saeki; Atsushi Nonami; Mika Sasaki; Masamitsu Kuriyama; Naoaki Saito; Masabumi Shibuya; Akihiko Yoshimura
Journal:  Nat Cell Biol       Date:  2003-05       Impact factor: 28.824

5.  Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation.

Authors:  J H Hanke; J P Gardner; R L Dow; P S Changelian; W H Brissette; E J Weringer; B A Pollok; P A Connelly
Journal:  J Biol Chem       Date:  1996-01-12       Impact factor: 5.157

6.  Tyrosine phosphorylation of Sprouty2 enhances its interaction with c-Cbl and is crucial for its function.

Authors:  Chee Wai Fong; Hwei Fen Leong; Esther Sook Miin Wong; Jormay Lim; Permeen Yusoff; Graeme R Guy
Journal:  J Biol Chem       Date:  2003-06-18       Impact factor: 5.157

7.  DNA synthesis induced by some but not all growth factors requires Src family protein tyrosine kinases.

Authors:  S Roche; M Koegl; M V Barone; M F Roussel; S A Courtneidge
Journal:  Mol Cell Biol       Date:  1995-02       Impact factor: 4.272

8.  Characterization of sites for tyrosine phosphorylation in the transforming protein of Rous sarcoma virus (pp60v-src) and its normal cellular homologue (pp60c-src).

Authors:  J E Smart; H Oppermann; A P Czernilofsky; A F Purchio; R L Erikson; J M Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

9.  Epidermal-growth-factor-dependent activation of the src-family kinases.

Authors:  N Osherov; A Levitzki
Journal:  Eur J Biochem       Date:  1994-11-01

10.  Vertebrate Sprouty genes are induced by FGF signaling and can cause chondrodysplasia when overexpressed.

Authors:  G Minowada; L A Jarvis; C L Chi; A Neubüser; X Sun; N Hacohen; M A Krasnow; G R Martin
Journal:  Development       Date:  1999-10       Impact factor: 6.868

View more
  52 in total

1.  Bimodal expression of Sprouty2 during the cell cycle is mediated by phase-specific Ras/MAPK and c-Cbl activities.

Authors:  Christoph-Erik Mayer; Barbara Haigl; Florian Jantscher; Gerald Siegwart; Michael Grusch; Walter Berger; Hedwig Sutterlüty
Journal:  Cell Mol Life Sci       Date:  2010-05-12       Impact factor: 9.261

2.  Sprouty2 downregulates angiogenesis during mouse skin wound healing.

Authors:  Mateusz S Wietecha; Lin Chen; Matthew J Ranzer; Kimberly Anderson; Chunyi Ying; Tarun B Patel; Luisa A DiPietro
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-11-12       Impact factor: 4.733

3.  Sprouty-4 inhibits transformed cell growth, migration and invasion, and epithelial-mesenchymal transition, and is regulated by Wnt7A through PPARgamma in non-small cell lung cancer.

Authors:  Meredith A Tennis; Michelle M Van Scoyk; Scott V Freeman; Katherine M Vandervest; Raphael A Nemenoff; Robert A Winn
Journal:  Mol Cancer Res       Date:  2010-05-25       Impact factor: 5.852

4.  Regulation of cellular levels of Sprouty2 protein by prolyl hydroxylase domain and von Hippel-Lindau proteins.

Authors:  Kimberly Anderson; Kyle A Nordquist; Xianlong Gao; Kristin C Hicks; Bo Zhai; Steven P Gygi; Tarun B Patel
Journal:  J Biol Chem       Date:  2011-10-17       Impact factor: 5.157

5.  Sprouty-2 overexpression in C2C12 cells confers myogenic differentiation properties in the presence of FGF2.

Authors:  Cristina de Alvaro; Natalia Martinez; Jose M Rojas; Margarita Lorenzo
Journal:  Mol Biol Cell       Date:  2005-07-06       Impact factor: 4.138

Review 6.  An essential role for FGF receptor signaling in lens development.

Authors:  Michael L Robinson
Journal:  Semin Cell Dev Biol       Date:  2006-10-27       Impact factor: 7.727

Review 7.  Receptor tyrosine kinase (RTK) signalling in the control of neural stem and progenitor cell (NSPC) development.

Authors:  Alexander Annenkov
Journal:  Mol Neurobiol       Date:  2013-08-28       Impact factor: 5.590

Review 8.  Tumor adaptation and resistance to RAF inhibitors.

Authors:  Piro Lito; Neal Rosen; David B Solit
Journal:  Nat Med       Date:  2013-11       Impact factor: 53.440

9.  Sprouty 2 disturbs FGFR3 degradation in thanatophoric dysplasia type II: a severe form of human achondroplasia.

Authors:  Changsheng Guo; Catherine R Degnin; Melanie B Laederich; Gregory P Lunstrum; Paul Holden; Jeanie Bihlmaier; Deborah Krakow; Yoon-Jae Cho; William A Horton
Journal:  Cell Signal       Date:  2008-04-10       Impact factor: 4.315

10.  Receptor tyrosine kinase ubiquitylation involves the dynamic regulation of Cbl-Spry2 by intersectin 1 and the Shp2 tyrosine phosphatase.

Authors:  Mustafa Nazir Okur; Angela Russo; John P O'Bryan
Journal:  Mol Cell Biol       Date:  2013-11-11       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.